{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:34:29Z","timestamp":1792722869573,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.mayocp.2013.02.007","type":"journal-article","created":{"date-parts":[[2013,4,17]],"date-time":"2013-04-17T04:22:30Z","timestamp":1366172550000},"page":"544-551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":176,"title":["L-Carnitine in the Secondary Prevention of Cardiovascular Disease: Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"88","author":[{"given":"James J.","family":"DiNicolantonio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl J.","family":"Lavie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Fares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur R.","family":"Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"O'Keefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2, suppl","key":"10.1016\/j.mayocp.2013.02.007_bib1","doi-asserted-by":"crossref","first-page":"e637S","DOI":"10.1378\/chest.11-2306","article-title":"Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Vandvik","year":"2012","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.mayocp.2013.02.007_bib2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0002-8703(79)90440-X","article-title":"Role of carnitine in fatty acid metabolism of normal and ischemic myocardium","volume":"97","author":"Opie","year":"1979","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.mayocp.2013.02.007_bib3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0003-9861(78)90003-6","article-title":"Changes in tissue levels of carnitine and other metabolites during myocardial ischemia and anoxia","volume":"187","author":"Shug","year":"1978","journal-title":"Arch Biochem Biophys"},{"issue":"6","key":"10.1016\/j.mayocp.2013.02.007_bib4","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/oxfordjournals.eurheartj.a059519","article-title":"High doses of L-carnitine in acute myocardial infarction: metabolic and antiarrhythmic effects","volume":"10","author":"Rizzon","year":"1989","journal-title":"Eur Heart J"},{"issue":"1, pt 2","key":"10.1016\/j.mayocp.2013.02.007_bib5","first-page":"H169","article-title":"Effects of L-propionylcarnitine on mechanical recovery during reflow in intact hearts","volume":"255","author":"Liedtke","year":"1988","journal-title":"Am J Physiol"},{"issue":"6, pt 2","key":"10.1016\/j.mayocp.2013.02.007_bib6","first-page":"H2190","article-title":"Propionyl-L-carnitine prevents myocardial mechanical alterations due to pressure overload in rats","volume":"266","author":"Micheletti","year":"1994","journal-title":"Am J Physiol"},{"issue":"2, pt 3","key":"10.1016\/j.mayocp.2013.02.007_bib7","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1067\/mhj.2000.103918","article-title":"Myocardial infarction and left ventricular remodeling: results of the CEDIM trial","volume":"139","author":"Colonna","year":"2000","journal-title":"Am Heart J"},{"issue":"1S","key":"10.1016\/j.mayocp.2013.02.007_bib8","first-page":"128","article-title":"L-Carnitine and cardiovascular disease: from basic science to clinical application","volume":"114","author":"Bai","year":"2009","journal-title":"Cardiology"},{"issue":"1","key":"10.1016\/j.mayocp.2013.02.007_bib9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/01.CIR.76.1.44","article-title":"Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction","volume":"76","author":"White","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.mayocp.2013.02.007_bib10","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.mayocp.2013.02.007_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"issue":"11","key":"10.1016\/j.mayocp.2013.02.007_bib12","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.mayocp.2013.02.007_bib13","series-title":"Cochran Handbook for Systematic Review of Interventions: Assessing Risk of Bias in Included Studies","year":"2008"},{"issue":"8","key":"10.1016\/j.mayocp.2013.02.007_bib14","first-page":"355","article-title":"Controlled study on L-carnitine therapeutic efficacy in post-infarction","volume":"18","author":"Davini","year":"1992","journal-title":"Drugs Exp Clin Res"},{"issue":"7","key":"10.1016\/j.mayocp.2013.02.007_bib15","first-page":"591","article-title":"L-Carnitine for the treatment of acute myocardial infarct [in Italian]","volume":"35","author":"De Pasquale","year":"1990","journal-title":"Cardiologia"},{"issue":"2","key":"10.1016\/j.mayocp.2013.02.007_bib16","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0735-1097(95)80010-E","article-title":"Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) Trial","volume":"26","author":"Iliceto","year":"1995","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.mayocp.2013.02.007_bib17","first-page":"38","article-title":"Does left ventricular function improve with L-carnitine after acute myocardial infarction?","volume":"45","author":"Iyer","year":"1999","journal-title":"J\u00a0Postgrad Med"},{"issue":"2","key":"10.1016\/j.mayocp.2013.02.007_bib18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2165\/00044011-199611020-00004","article-title":"Effect of L-carnitine on the limitation of infarct size in on-month postmyocardial infarction cases: a multicentre, randomised, parallel, placebo-controlled trial","volume":"11","author":"Jacoba","year":"1996","journal-title":"Clin Drug Investig"},{"issue":"3","key":"10.1016\/j.mayocp.2013.02.007_bib19","first-page":"240","article-title":"Effects of carnitine on 6-month incidence of mortality and heart failure in patients with acute myocardial infarction","volume":"2","author":"Kobulia","year":"2002","journal-title":"Ann Biomed Res Educ"},{"issue":"37","key":"10.1016\/j.mayocp.2013.02.007_bib20","first-page":"1352","article-title":"Anti-arrhythmia treatment using L-carnitine in acute myocardial infarct [in German]","volume":"122","author":"Martina","year":"1992","journal-title":"Schweiz Med Wochenschr"},{"issue":"4","key":"10.1016\/j.mayocp.2013.02.007_bib21","first-page":"251","article-title":"The effect of L-carnitine on left ventricular function in patients with acute myocardial infarction treated with streptokinase","volume":"24","author":"Pehlivanoglu","year":"1996","journal-title":"T\u00fcrk Kardiyol Dern Ar\u015f-Arch Turk Soc Cardiol"},{"key":"10.1016\/j.mayocp.2013.02.007_bib22","first-page":"219","article-title":"Beneficial effects of L-carnitine in the reduction of the necrotic area in acute myocardial infarction","volume":"10","author":"Rebuzzi","year":"1984","journal-title":"Drugs Exp Clin Res"},{"issue":"843","key":"10.1016\/j.mayocp.2013.02.007_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/pgmj.72.843.45","article-title":"A\u00a0randomised, double-blind, placebo-controlled trial of L-carnitine in suspected acute myocardial infarction","volume":"72","author":"Singh","year":"1996","journal-title":"Postgrad Med J"},{"issue":"4","key":"10.1016\/j.mayocp.2013.02.007_bib24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000093131","article-title":"Metabolic treatment with L-carnitine in acute anterior ST segment elevation myocardial infarction: a randomized controlled trial","volume":"106","author":"Tarantini","year":"2006","journal-title":"Cardiology"},{"issue":"6","key":"10.1016\/j.mayocp.2013.02.007_bib25","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10557-007-6056-9","article-title":"L-Carnitine as an adjunct therapy to percutaneous coronary intervention for non-ST elevation myocardial infarction","volume":"21","author":"Xue","year":"2007","journal-title":"Cardiovasc Drugs Ther"},{"issue":"8","key":"10.1016\/j.mayocp.2013.02.007_bib26","first-page":"533","article-title":"Carnitine metabolism and deficiency syndromes","volume":"58","author":"Rebouche","year":"1983","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.mayocp.2013.02.007_bib27","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1253\/jcj.45.687","article-title":"Effects of L-carnitine on tissue levels of acyl carnitine, acyl coenzyme A and high energy phosphate in ischemic dog hearts","volume":"45","author":"Suzuki","year":"1981","journal-title":"Jpn Circ J"},{"issue":"8286","key":"10.1016\/j.mayocp.2013.02.007_bib28","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0140-6736(82)92540-5","article-title":"Myocardial carnitine deficiency in acute myocardial infarction","volume":"1","author":"Spagnoli","year":"1982","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.mayocp.2013.02.007_bib29","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0002-9149(90)91383-H","article-title":"Defective myocardial carnitine metabolism in congestive heart failure secondary to dilated cardiomyopathy and to coronary, hypertensive and valvular heart diseases","volume":"65","author":"Regitz","year":"1990","journal-title":"Am J Cardiol"},{"issue":"8666","key":"10.1016\/j.mayocp.2013.02.007_bib30","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(89)90828-3","article-title":"Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and Reinfarction Trial (DART)","volume":"2","author":"Burr","year":"1989","journal-title":"Lancet"},{"issue":"suppl","key":"10.1016\/j.mayocp.2013.02.007_bib31","first-page":"S119","article-title":"Efficacy of n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione trial","volume":"36","author":"Marchioli","year":"2001","journal-title":"Lipids"},{"issue":"21","key":"10.1016\/j.mayocp.2013.02.007_bib32","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1161\/CIRCULATIONAHA.110.948562","article-title":"OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction","volume":"122","author":"Rauch","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.mayocp.2013.02.007_bib33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1745-6215-9-35","article-title":"The SU.FOL.OM3 Study: a secondary prevention trial testing the impact of supplementation with folate and B-vitamins and\/or Omega-3 PUFA on fatal and non fatal cardiovascular events, design, methods and participants characteristics","volume":"9","author":"Galan","year":"2008","journal-title":"Trials"},{"issue":"7511","key":"10.1016\/j.mayocp.2013.02.007_bib34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/bmj.331.7511.281","article-title":"Suspected research fraud: difficulties of getting at the truth","volume":"331","author":"White","year":"2005","journal-title":"BMJ"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619613001274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619613001274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:29:08Z","timestamp":1758418148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619613001274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0025619613001274"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2013.02.007","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"L-Carnitine in the Secondary Prevention of Cardiovascular Disease: Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2013.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}